Several papers have established the involvement of EGFR in ROR1-mediated survival signaling within carcinomas [31,39], which may not be able to explain why ROR1 is expressed the highest in the sarcoma and mesothelioma and predicts bad prognosis in these cancers (Supplementary Figure S1a). Here, EGFR is linked to sarcoma.